BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 23/08/2018

FDA Announces Draft Guidance for Osteoarthritis Treatment Development

The FDA is releasing a draft guidance to help pharmaceutical companies develop effective treatments for osteoarthritis, focusing on structural endpoints rather than symptom relief.

Source: Federal Register — Food and Drug AdministrationOpen original release →